HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r)+2-3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r plus Raltegravir as Second-Line Antiretroviral Therapy

Martin, Allison, Moore, Cecilia L., Mallon, Patrick W. G., Hoy, Jennifer F., Emery, Sean, Belloso, Waldo H., Phanuphak, Praphan, Ferret, Samuel, Cooper, David A. and Boyd, Mark A. (2013) HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r)+2-3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r plus Raltegravir as Second-Line Antiretroviral Therapy. Plos One, 8 10: . doi:10.1371/journal.pone.0077138


Author Martin, Allison
Moore, Cecilia L.
Mallon, Patrick W. G.
Hoy, Jennifer F.
Emery, Sean
Belloso, Waldo H.
Phanuphak, Praphan
Ferret, Samuel
Cooper, David A.
Boyd, Mark A.
Title HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r)+2-3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r plus Raltegravir as Second-Line Antiretroviral Therapy
Journal name Plos One   Check publisher's open access policy
ISSN 1932-6203
Publication date 2013-10-01
Sub-type Article (original research)
DOI 10.1371/journal.pone.0077138
Open Access Status DOI
Volume 8
Issue 10
Total pages 9
Publisher PUBLIC LIBRARY SCIENCE
Language eng
Keyword Nucleoside Analog Therapy
Body-Composition Changes
Metabolic Syndrome
Protease Inhibitors
Hiv-1-Infected Patients
Cardiovascular Risk
Infected Patients
Naive Subjects
Myocardial-Infarction
Fat Distribution
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 8 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 18 Mar 2017, 01:00:47 EST by Web Cron